

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | tricarboxylic acid cycle (GO:0006099) | 7.64246292 |
| 2 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 6.25091981 |
| 3 | NADH metabolic process (GO:0006734) | 6.17652904 |
| 4 | ATP synthesis coupled proton transport (GO:0015986) | 5.74306301 |
| 5 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.74306301 |
| 6 | lysine metabolic process (GO:0006553) | 5.72305897 |
| 7 | lysine catabolic process (GO:0006554) | 5.72305897 |
| 8 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.71140610 |
| 9 | succinate metabolic process (GO:0006105) | 5.53865530 |
| 10 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 5.48763902 |
| 11 | * respiratory electron transport chain (GO:0022904) | 5.33011864 |
| 12 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.31551963 |
| 13 | creatine metabolic process (GO:0006600) | 5.28577986 |
| 14 | * electron transport chain (GO:0022900) | 5.18803224 |
| 15 | regulation of cofactor metabolic process (GO:0051193) | 5.12602854 |
| 16 | regulation of coenzyme metabolic process (GO:0051196) | 5.12602854 |
| 17 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 5.08351241 |
| 18 | aspartate family amino acid catabolic process (GO:0009068) | 4.99298099 |
| 19 | oxaloacetate metabolic process (GO:0006107) | 4.87377013 |
| 20 | 2-oxoglutarate metabolic process (GO:0006103) | 4.87216000 |
| 21 | carnitine shuttle (GO:0006853) | 4.71134124 |
| 22 | cellular ketone body metabolic process (GO:0046950) | 4.69255028 |
| 23 | fatty acid beta-oxidation (GO:0006635) | 4.63994434 |
| 24 | * oxidative phosphorylation (GO:0006119) | 4.53875335 |
| 25 | fatty acid transmembrane transport (GO:1902001) | 4.47871830 |
| 26 | striated muscle contraction (GO:0006941) | 4.42654328 |
| 27 | branched-chain amino acid catabolic process (GO:0009083) | 4.42238326 |
| 28 | skeletal muscle contraction (GO:0003009) | 4.41138940 |
| 29 | acetyl-CoA metabolic process (GO:0006084) | 4.30012193 |
| 30 | sarcomere organization (GO:0045214) | 4.19051713 |
| 31 | regulation of sulfur metabolic process (GO:0042762) | 4.18160104 |
| 32 | tricarboxylic acid metabolic process (GO:0072350) | 4.16385473 |
| 33 | fatty acid catabolic process (GO:0009062) | 4.13300590 |
| 34 | short-chain fatty acid metabolic process (GO:0046459) | 4.11975841 |
| 35 | fatty acid oxidation (GO:0019395) | 4.09263007 |
| 36 | ketone body metabolic process (GO:1902224) | 4.07346575 |
| 37 | glyoxylate metabolic process (GO:0046487) | 4.03765584 |
| 38 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.02817091 |
| 39 | lipid oxidation (GO:0034440) | 4.01215313 |
| 40 | branched-chain amino acid metabolic process (GO:0009081) | 4.01025098 |
| 41 | formation of translation preinitiation complex (GO:0001731) | 4.00468983 |
| 42 | fructose metabolic process (GO:0006000) | 3.93267137 |
| 43 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.91035055 |
| 44 | cardiac myofibril assembly (GO:0055003) | 3.89129971 |
| 45 | monosaccharide biosynthetic process (GO:0046364) | 3.82868554 |
| 46 | glycolytic process (GO:0006096) | 3.82440791 |
| 47 | ATP biosynthetic process (GO:0006754) | 3.81056800 |
| 48 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.80994343 |
| 49 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.80968191 |
| 50 | L-phenylalanine metabolic process (GO:0006558) | 3.80968191 |
| 51 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.75965954 |
| 52 | L-phenylalanine catabolic process (GO:0006559) | 3.75965954 |
| 53 | regulation of sequestering of triglyceride (GO:0010889) | 3.69722937 |
| 54 | monocarboxylic acid catabolic process (GO:0072329) | 3.69649920 |
| 55 | valine metabolic process (GO:0006573) | 3.67376105 |
| 56 | carnitine transport (GO:0015879) | 3.66260792 |
| 57 | amino-acid betaine transport (GO:0015838) | 3.66260792 |
| 58 | actin filament-based movement (GO:0030048) | 3.64542357 |
| 59 | carnitine transmembrane transport (GO:1902603) | 3.63400793 |
| 60 | regulation of fatty acid oxidation (GO:0046320) | 3.61270386 |
| 61 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.60380874 |
| 62 | muscle filament sliding (GO:0030049) | 3.59717209 |
| 63 | actin-myosin filament sliding (GO:0033275) | 3.59717209 |
| 64 | cardiac muscle contraction (GO:0060048) | 3.53392192 |
| 65 | IMP metabolic process (GO:0046040) | 3.53274500 |
| 66 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.50312957 |
| 67 | proline biosynthetic process (GO:0006561) | 3.49884990 |
| 68 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.49161671 |
| 69 | amino-acid betaine metabolic process (GO:0006577) | 3.45601894 |
| 70 | Golgi transport vesicle coating (GO:0048200) | 3.44089522 |
| 71 | COPI coating of Golgi vesicle (GO:0048205) | 3.44089522 |
| 72 | carnitine metabolic process (GO:0009437) | 3.41412810 |
| 73 | myofibril assembly (GO:0030239) | 3.38104419 |
| 74 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.37359660 |
| 75 | mitochondrial fusion (GO:0008053) | 3.33167808 |
| 76 | inner mitochondrial membrane organization (GO:0007007) | 3.32159561 |
| 77 | gluconeogenesis (GO:0006094) | 3.29985294 |
| 78 | regulation of translational fidelity (GO:0006450) | 3.29621529 |
| 79 | biotin metabolic process (GO:0006768) | 3.24641333 |
| 80 | response to muscle activity (GO:0014850) | 3.23928000 |
| 81 | ribosomal large subunit biogenesis (GO:0042273) | 3.23151870 |
| 82 | pyruvate metabolic process (GO:0006090) | 3.20422849 |
| 83 | alpha-linolenic acid metabolic process (GO:0036109) | 3.16982040 |
| 84 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.16965734 |
| 85 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.15211336 |
| 86 | quinone biosynthetic process (GO:1901663) | 3.14984006 |
| 87 | ubiquinone biosynthetic process (GO:0006744) | 3.14984006 |
| 88 | cysteine metabolic process (GO:0006534) | 3.14634941 |
| 89 | acyl-CoA metabolic process (GO:0006637) | 3.14212670 |
| 90 | thioester metabolic process (GO:0035383) | 3.14212670 |
| 91 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.13982559 |
| 92 | kynurenine metabolic process (GO:0070189) | 3.13660375 |
| 93 | viral transcription (GO:0019083) | 3.12295792 |
| 94 | aromatic amino acid family catabolic process (GO:0009074) | 3.11943182 |
| 95 | thioester biosynthetic process (GO:0035384) | 3.11296299 |
| 96 | acyl-CoA biosynthetic process (GO:0071616) | 3.11296299 |
| 97 | quaternary ammonium group transport (GO:0015697) | 3.11226673 |
| 98 | hexose biosynthetic process (GO:0019319) | 3.09430322 |
| 99 | IMP biosynthetic process (GO:0006188) | 3.08931912 |
| 100 | NAD metabolic process (GO:0019674) | 3.08283512 |
| 101 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.08177025 |
| 102 | regulation of relaxation of muscle (GO:1901077) | 3.07363609 |
| 103 | carboxylic acid catabolic process (GO:0046395) | 3.07099175 |
| 104 | organic acid catabolic process (GO:0016054) | 3.07099175 |
| 105 | positive regulation of fatty acid oxidation (GO:0046321) | 3.06187680 |
| 106 | actomyosin structure organization (GO:0031032) | 3.05899677 |
| 107 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.04214523 |
| 108 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.03157406 |
| 109 | glucan biosynthetic process (GO:0009250) | 3.01766396 |
| 110 | glycogen biosynthetic process (GO:0005978) | 3.01766396 |
| 111 | translational termination (GO:0006415) | 3.01389179 |
| 112 | alpha-amino acid catabolic process (GO:1901606) | 3.00932323 |
| 113 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.00907743 |
| 114 | fatty acid homeostasis (GO:0055089) | 3.00778051 |
| 115 | heart contraction (GO:0060047) | 3.00776375 |
| 116 | heart process (GO:0003015) | 3.00776375 |
| 117 | regulation of actin filament-based movement (GO:1903115) | 2.97985165 |
| 118 | regulation of triglyceride catabolic process (GO:0010896) | 2.97447787 |
| 119 | dicarboxylic acid catabolic process (GO:0043649) | 2.97335286 |
| 120 | dicarboxylic acid metabolic process (GO:0043648) | 2.96007227 |
| 121 | cellular amino acid catabolic process (GO:0009063) | 2.94631304 |
| 122 | regulation of skeletal muscle contraction (GO:0014819) | 2.93677438 |
| 123 | regulation of cell communication by electrical coupling (GO:0010649) | 2.93619929 |
| 124 | glycogen catabolic process (GO:0005980) | 2.92735379 |
| 125 | actin-mediated cell contraction (GO:0070252) | 2.91842431 |
| 126 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.91804233 |
| 127 | cardiac muscle hypertrophy (GO:0003300) | 2.91511326 |
| 128 | * aerobic respiration (GO:0009060) | 2.91095948 |
| 129 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.87775494 |
| 130 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.86699727 |
| 131 | purine nucleoside monophosphate biosynthetic process (GO:0009127) | 2.84648152 |
| 132 | purine ribonucleoside monophosphate biosynthetic process (GO:0009168) | 2.84648152 |
| 133 | striated muscle hypertrophy (GO:0014897) | 2.84136449 |
| 134 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.82662478 |
| 135 | 4-hydroxyproline metabolic process (GO:0019471) | 2.79172706 |
| 136 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.77938201 |
| 137 | glucan catabolic process (GO:0009251) | 2.77775657 |
| 138 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.76726636 |
| 139 | ribosomal small subunit assembly (GO:0000028) | 2.74555259 |
| 140 | * cellular respiration (GO:0045333) | 2.74345375 |
| 141 | translational elongation (GO:0006414) | 2.74197778 |
| 142 | cell communication involved in cardiac conduction (GO:0086065) | 2.72935409 |
| 143 | tRNA aminoacylation for protein translation (GO:0006418) | 2.70950870 |
| 144 | proline metabolic process (GO:0006560) | 2.70872955 |
| 145 | translational initiation (GO:0006413) | 2.70606635 |
| 146 | AMP metabolic process (GO:0046033) | 2.68029242 |
| 147 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.67385037 |
| 148 | cellular polysaccharide catabolic process (GO:0044247) | 2.65831995 |
| 149 | muscle contraction (GO:0006936) | 2.65530453 |
| 150 | muscle tissue morphogenesis (GO:0060415) | 2.64777421 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 8.57123656 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.44288503 |
| 3 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 5.04182969 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.70063315 |
| 5 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.44507971 |
| 6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.26756034 |
| 7 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.21754058 |
| 8 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.85482709 |
| 9 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.63067837 |
| 10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.25250438 |
| 11 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.81631587 |
| 12 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.79215535 |
| 13 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.71350569 |
| 14 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.70050945 |
| 15 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.55794068 |
| 16 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.53262216 |
| 17 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.51454489 |
| 18 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.47528288 |
| 19 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.42098915 |
| 20 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.34956390 |
| 21 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.31412021 |
| 22 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.24484950 |
| 23 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.19580541 |
| 24 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.19245504 |
| 25 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.09020253 |
| 26 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.07489266 |
| 27 | * CLOCK_20551151_ChIP-Seq_293T_Human | 2.06389975 |
| 28 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.00880199 |
| 29 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.94829684 |
| 30 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.88841702 |
| 31 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.84761721 |
| 32 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.82630919 |
| 33 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.78767612 |
| 34 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.71567024 |
| 35 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.69924346 |
| 36 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.68847709 |
| 37 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.68779013 |
| 38 | * E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.65445076 |
| 39 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.63827875 |
| 40 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.61878580 |
| 41 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.58830265 |
| 42 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.58526689 |
| 43 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.58526689 |
| 44 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.54280540 |
| 45 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.49840257 |
| 46 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.49460583 |
| 47 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.48213624 |
| 48 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.46414039 |
| 49 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.44556497 |
| 50 | GATA1_22025678_ChIP-Seq_K562_Human | 1.44101457 |
| 51 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.43389848 |
| 52 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.39636365 |
| 53 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.38046162 |
| 54 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.36447966 |
| 55 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.31304490 |
| 56 | * GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.28013156 |
| 57 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.26657636 |
| 58 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.26288792 |
| 59 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.25586011 |
| 60 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.24868812 |
| 61 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.24352020 |
| 62 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.24258779 |
| 63 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.23319634 |
| 64 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.23185856 |
| 65 | VDR_22108803_ChIP-Seq_LS180_Human | 1.21114928 |
| 66 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.20997073 |
| 67 | * ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.20864377 |
| 68 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.20676449 |
| 69 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.19627036 |
| 70 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.17803395 |
| 71 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.14240644 |
| 72 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.13865054 |
| 73 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.13319914 |
| 74 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.12657406 |
| 75 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.12625323 |
| 76 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.12522866 |
| 77 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 1.12075163 |
| 78 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.09331105 |
| 79 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.08879174 |
| 80 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.04923642 |
| 81 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.04458102 |
| 82 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.04243354 |
| 83 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.02227466 |
| 84 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.01563845 |
| 85 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.01001380 |
| 86 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.00498991 |
| 87 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.00186481 |
| 88 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.00106213 |
| 89 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98639823 |
| 90 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.98333327 |
| 91 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.97289607 |
| 92 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.96920203 |
| 93 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.96824124 |
| 94 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.95528229 |
| 95 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.94925525 |
| 96 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.93598139 |
| 97 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.92873092 |
| 98 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.91964152 |
| 99 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.89763915 |
| 100 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.88203532 |
| 101 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.88108718 |
| 102 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.87212415 |
| 103 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.86922808 |
| 104 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.86581547 |
| 105 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.86514405 |
| 106 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.86104290 |
| 107 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.84801764 |
| 108 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.84419498 |
| 109 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.83904141 |
| 110 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.82880528 |
| 111 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.81850305 |
| 112 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.80201030 |
| 113 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.79091415 |
| 114 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.77940160 |
| 115 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.77940160 |
| 116 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.77031989 |
| 117 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.75474931 |
| 118 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.73245530 |
| 119 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.72940996 |
| 120 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.72825447 |
| 121 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.72073194 |
| 122 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.71322487 |
| 123 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.70778333 |
| 124 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.69135158 |
| 125 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.68979058 |
| 126 | CBP_21632823_ChIP-Seq_H3396_Human | 0.68810887 |
| 127 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.68477483 |
| 128 | NCOR_22424771_ChIP-Seq_293T_Human | 0.68132993 |
| 129 | * NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.67176031 |
| 130 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.67092719 |
| 131 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.67092719 |
| 132 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.66569695 |
| 133 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.66440128 |
| 134 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.66345453 |
| 135 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.66282779 |
| 136 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.65904534 |
| 137 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.64591478 |
| 138 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.64298586 |
| 139 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.63386402 |
| 140 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.62053556 |
| 141 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.61883961 |
| 142 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.61387876 |
| 143 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.60995034 |
| 144 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.60715780 |
| 145 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.60018527 |
| 146 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.59822372 |
| 147 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.59822372 |
| 148 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.59079524 |
| 149 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.58731036 |
| 150 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.58278685 |
| 151 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.57657474 |
| 152 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.57602988 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 5.19219480 |
| 2 | MP0003646_muscle_fatigue | 4.22593108 |
| 3 | MP0005360_urolithiasis | 4.06853562 |
| 4 | MP0004084_abnormal_cardiac_muscle | 3.72600433 |
| 5 | MP0002139_abnormal_hepatobiliary_system | 3.69835529 |
| 6 | MP0004215_abnormal_myocardial_fiber | 3.51563925 |
| 7 | MP0000751_myopathy | 3.38566573 |
| 8 | MP0004036_abnormal_muscle_relaxation | 3.17963274 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 3.16382622 |
| 10 | MP0005085_abnormal_gallbladder_physiolo | 3.11952456 |
| 11 | MP0006036_abnormal_mitochondrial_physio | 3.09146297 |
| 12 | MP0005330_cardiomyopathy | 2.86869687 |
| 13 | MP0004130_abnormal_muscle_cell | 2.78776513 |
| 14 | MP0005365_abnormal_bile_salt | 2.77131013 |
| 15 | MP0000749_muscle_degeneration | 2.67563643 |
| 16 | MP0008875_abnormal_xenobiotic_pharmacok | 2.56751443 |
| 17 | MP0005332_abnormal_amino_acid | 2.31511211 |
| 18 | MP0004043_abnormal_pH_regulation | 2.30788074 |
| 19 | MP0003195_calcinosis | 2.29330094 |
| 20 | MP0002972_abnormal_cardiac_muscle | 2.20558385 |
| 21 | MP0006035_abnormal_mitochondrial_morpho | 2.10976198 |
| 22 | MP0008775_abnormal_heart_ventricle | 2.10007531 |
| 23 | MP0005620_abnormal_muscle_contractility | 2.06242419 |
| 24 | MP0001661_extended_life_span | 2.04170521 |
| 25 | MP0004087_abnormal_muscle_fiber | 2.02656131 |
| 26 | MP0004484_altered_response_of | 1.91601674 |
| 27 | MP0003221_abnormal_cardiomyocyte_apopto | 1.88403203 |
| 28 | MP0003137_abnormal_impulse_conducting | 1.87741951 |
| 29 | MP0010329_abnormal_lipoprotein_level | 1.86210418 |
| 30 | MP0001544_abnormal_cardiovascular_syste | 1.77593140 |
| 31 | MP0005385_cardiovascular_system_phenoty | 1.77593140 |
| 32 | MP0002269_muscular_atrophy | 1.76161297 |
| 33 | MP0010234_abnormal_vibrissa_follicle | 1.73092713 |
| 34 | MP0004145_abnormal_muscle_electrophysio | 1.72463984 |
| 35 | MP0006138_congestive_heart_failure | 1.67939391 |
| 36 | MP0000747_muscle_weakness | 1.66592068 |
| 37 | MP0004957_abnormal_blastocyst_morpholog | 1.65938901 |
| 38 | MP0002106_abnormal_muscle_physiology | 1.63454573 |
| 39 | MP0003693_abnormal_embryo_hatching | 1.58668848 |
| 40 | MP0005666_abnormal_adipose_tissue | 1.54948372 |
| 41 | MP0005670_abnormal_white_adipose | 1.54523215 |
| 42 | MP0004085_abnormal_heartbeat | 1.50900944 |
| 43 | MP0003252_abnormal_bile_duct | 1.47157794 |
| 44 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.45858056 |
| 45 | MP0004233_abnormal_muscle_weight | 1.44602996 |
| 46 | MP0010630_abnormal_cardiac_muscle | 1.42663839 |
| 47 | MP0004270_analgesia | 1.42249571 |
| 48 | MP0000750_abnormal_muscle_regeneration | 1.42235797 |
| 49 | MP0002118_abnormal_lipid_homeostasis | 1.40383035 |
| 50 | MP0001666_abnormal_nutrient_absorption | 1.37955592 |
| 51 | MP0005319_abnormal_enzyme/_coenzyme | 1.34622065 |
| 52 | MP0002332_abnormal_exercise_endurance | 1.34331993 |
| 53 | MP0004147_increased_porphyrin_level | 1.33812281 |
| 54 | MP0005369_muscle_phenotype | 1.29562525 |
| 55 | MP0005535_abnormal_body_temperature | 1.25468379 |
| 56 | MP0000013_abnormal_adipose_tissue | 1.25021202 |
| 57 | MP0002971_abnormal_brown_adipose | 1.23583889 |
| 58 | MP0000759_abnormal_skeletal_muscle | 1.21942041 |
| 59 | MP0001730_embryonic_growth_arrest | 1.21396947 |
| 60 | MP0005266_abnormal_metabolism | 1.21190340 |
| 61 | MP0002822_catalepsy | 1.18861321 |
| 62 | MP0008932_abnormal_embryonic_tissue | 1.18634759 |
| 63 | MP0009643_abnormal_urine_homeostasis | 1.15502360 |
| 64 | MP0003111_abnormal_nucleus_morphology | 1.13479673 |
| 65 | MP0005451_abnormal_body_composition | 1.10555872 |
| 66 | MP0000230_abnormal_systemic_arterial | 1.09033484 |
| 67 | MP0005083_abnormal_biliary_tract | 1.07429934 |
| 68 | MP0002078_abnormal_glucose_homeostasis | 1.07124664 |
| 69 | MP0003315_abnormal_perineum_morphology | 1.06254286 |
| 70 | MP0001764_abnormal_homeostasis | 1.05999333 |
| 71 | MP0004264_abnormal_extraembryonic_tissu | 1.04978737 |
| 72 | MP0005636_abnormal_mineral_homeostasis | 1.01574130 |
| 73 | MP0009840_abnormal_foam_cell | 1.01255251 |
| 74 | MP0003186_abnormal_redox_activity | 1.00401821 |
| 75 | MP0003329_amyloid_beta_deposits | 0.98978550 |
| 76 | MP0004185_abnormal_adipocyte_glucose | 0.97400452 |
| 77 | MP0000609_abnormal_liver_physiology | 0.96812502 |
| 78 | MP0003941_abnormal_skin_development | 0.95880923 |
| 79 | MP0005375_adipose_tissue_phenotype | 0.95191523 |
| 80 | MP0001727_abnormal_embryo_implantation | 0.94217973 |
| 81 | MP0002127_abnormal_cardiovascular_syste | 0.92216394 |
| 82 | MP0004019_abnormal_vitamin_homeostasis | 0.91989109 |
| 83 | MP0010094_abnormal_chromosome_stability | 0.91434524 |
| 84 | MP0002909_abnormal_adrenal_gland | 0.87369132 |
| 85 | MP0001756_abnormal_urination | 0.84675962 |
| 86 | MP0003984_embryonic_growth_retardation | 0.84185726 |
| 87 | MP0002876_abnormal_thyroid_physiology | 0.83436147 |
| 88 | MP0003077_abnormal_cell_cycle | 0.83038688 |
| 89 | MP0003191_abnormal_cellular_cholesterol | 0.82742220 |
| 90 | MP0002108_abnormal_muscle_morphology | 0.81157328 |
| 91 | MP0001765_abnormal_ion_homeostasis | 0.80512361 |
| 92 | MP0000733_abnormal_muscle_development | 0.80433532 |
| 93 | MP0001529_abnormal_vocalization | 0.79003559 |
| 94 | MP0002088_abnormal_embryonic_growth/wei | 0.78802355 |
| 95 | MP0005165_increased_susceptibility_to | 0.78674430 |
| 96 | MP0009697_abnormal_copulation | 0.77737277 |
| 97 | MP0009672_abnormal_birth_weight | 0.76287409 |
| 98 | MP0003656_abnormal_erythrocyte_physiolo | 0.74074704 |
| 99 | MP0005380_embryogenesis_phenotype | 0.72302153 |
| 100 | MP0001672_abnormal_embryogenesis/_devel | 0.72302153 |
| 101 | MP0005376_homeostasis/metabolism_phenot | 0.71800565 |
| 102 | MP0003828_pulmonary_edema | 0.71021252 |
| 103 | MP0008058_abnormal_DNA_repair | 0.70694157 |
| 104 | MP0003868_abnormal_feces_composition | 0.69926382 |
| 105 | MP0003567_abnormal_fetal_cardiomyocyte | 0.69815300 |
| 106 | MP0009780_abnormal_chondrocyte_physiolo | 0.69284668 |
| 107 | MP0002009_preneoplasia | 0.68971639 |
| 108 | MP0003950_abnormal_plasma_membrane | 0.68294719 |
| 109 | MP0002080_prenatal_lethality | 0.66749277 |
| 110 | MP0004924_abnormal_behavior | 0.66241146 |
| 111 | MP0005386_behavior/neurological_phenoty | 0.66241146 |
| 112 | MP0000003_abnormal_adipose_tissue | 0.65593344 |
| 113 | MP0005448_abnormal_energy_balance | 0.65287375 |
| 114 | MP0001346_abnormal_lacrimal_gland | 0.64020578 |
| 115 | MP0009379_abnormal_foot_pigmentation | 0.63640681 |
| 116 | MP0000566_synostosis | 0.63207292 |
| 117 | MP0001697_abnormal_embryo_size | 0.60989938 |
| 118 | MP0005334_abnormal_fat_pad | 0.59452240 |
| 119 | MP0005187_abnormal_penis_morphology | 0.57662015 |
| 120 | MP0001984_abnormal_olfaction | 0.57567656 |
| 121 | MP0005058_abnormal_lysosome_morphology | 0.57306808 |
| 122 | MP0005452_abnormal_adipose_tissue | 0.55475816 |
| 123 | MP0000604_amyloidosis | 0.54884736 |
| 124 | MP0003953_abnormal_hormone_level | 0.53469439 |
| 125 | MP0009642_abnormal_blood_homeostasis | 0.52042489 |
| 126 | MP0008872_abnormal_physiological_respon | 0.50702791 |
| 127 | MP0003880_abnormal_central_pattern | 0.50102423 |
| 128 | MP0000266_abnormal_heart_morphology | 0.49865543 |
| 129 | MP0000358_abnormal_cell_content/ | 0.47777458 |
| 130 | MP0009745_abnormal_behavioral_response | 0.47550891 |
| 131 | MP0003959_abnormal_lean_body | 0.47266465 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 6.52628124 |
| 2 | Nemaline bodies (HP:0003798) | 6.44380465 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 6.31823058 |
| 4 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.84166786 |
| 5 | Acute necrotizing encephalopathy (HP:0006965) | 4.76544394 |
| 6 | Acute encephalopathy (HP:0006846) | 4.64670722 |
| 7 | Myoglobinuria (HP:0002913) | 4.59305223 |
| 8 | Hepatic necrosis (HP:0002605) | 4.50606250 |
| 9 | Type 1 muscle fiber predominance (HP:0003803) | 4.44788147 |
| 10 | Sudden death (HP:0001699) | 4.30147282 |
| 11 | Exercise-induced myalgia (HP:0003738) | 4.28133529 |
| 12 | Cerebral edema (HP:0002181) | 4.27433836 |
| 13 | Exercise-induced muscle cramps (HP:0003710) | 4.14771197 |
| 14 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.08000004 |
| 15 | Progressive macrocephaly (HP:0004481) | 4.03514344 |
| 16 | Hypoglycemic coma (HP:0001325) | 4.02838911 |
| 17 | Ketoacidosis (HP:0001993) | 3.98663842 |
| 18 | Hepatocellular necrosis (HP:0001404) | 3.97371619 |
| 19 | Mitochondrial inheritance (HP:0001427) | 3.91671786 |
| 20 | Myopathic facies (HP:0002058) | 3.88484207 |
| 21 | Increased CSF lactate (HP:0002490) | 3.86249385 |
| 22 | Rhabdomyolysis (HP:0003201) | 3.77445535 |
| 23 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.76036886 |
| 24 | Rimmed vacuoles (HP:0003805) | 3.72750129 |
| 25 | Dicarboxylic aciduria (HP:0003215) | 3.72344901 |
| 26 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.72344901 |
| 27 | Palpitations (HP:0001962) | 3.67691242 |
| 28 | Ketosis (HP:0001946) | 3.64950296 |
| 29 | Hyperglycinuria (HP:0003108) | 3.62057727 |
| 30 | Calf muscle hypertrophy (HP:0008981) | 3.57984822 |
| 31 | Lactic acidosis (HP:0003128) | 3.45262443 |
| 32 | Distal arthrogryposis (HP:0005684) | 3.43076704 |
| 33 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.41645494 |
| 34 | Abnormality of glycine metabolism (HP:0010895) | 3.36796523 |
| 35 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.36796523 |
| 36 | Increased muscle lipid content (HP:0009058) | 3.33397045 |
| 37 | * Hyperammonemia (HP:0001987) | 3.33072749 |
| 38 | Ventricular tachycardia (HP:0004756) | 3.26592881 |
| 39 | Pheochromocytoma (HP:0002666) | 3.26394422 |
| 40 | Generalized aminoaciduria (HP:0002909) | 3.17940608 |
| 41 | Conjunctival hamartoma (HP:0100780) | 3.15331310 |
| 42 | Ragged-red muscle fibers (HP:0003200) | 3.12730184 |
| 43 | Lethargy (HP:0001254) | 3.11398099 |
| 44 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.11080898 |
| 45 | Abnormality of alanine metabolism (HP:0010916) | 3.11080898 |
| 46 | Hyperalaninemia (HP:0003348) | 3.11080898 |
| 47 | Neck muscle weakness (HP:0000467) | 3.06557216 |
| 48 | Neuroendocrine neoplasm (HP:0100634) | 3.05702799 |
| 49 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.04311710 |
| 50 | * Abnormality of glycolysis (HP:0004366) | 3.01936983 |
| 51 | * Increased serum pyruvate (HP:0003542) | 3.01936983 |
| 52 | Increased intramyocellular lipid droplets (HP:0012240) | 2.98329039 |
| 53 | Respiratory failure (HP:0002878) | 2.98080819 |
| 54 | Hyperglycinemia (HP:0002154) | 2.93930814 |
| 55 | Exercise intolerance (HP:0003546) | 2.88224702 |
| 56 | Right ventricular cardiomyopathy (HP:0011663) | 2.83534840 |
| 57 | Distal lower limb muscle weakness (HP:0009053) | 2.81800321 |
| 58 | Progressive muscle weakness (HP:0003323) | 2.81691483 |
| 59 | Syncope (HP:0001279) | 2.81106163 |
| 60 | Atrial fibrillation (HP:0005110) | 2.79375325 |
| 61 | Lipoatrophy (HP:0100578) | 2.74146192 |
| 62 | Abnormality of the calf musculature (HP:0001430) | 2.73912230 |
| 63 | Gout (HP:0001997) | 2.73298152 |
| 64 | * Metabolic acidosis (HP:0001942) | 2.68434918 |
| 65 | Proximal tubulopathy (HP:0000114) | 2.68176045 |
| 66 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.65022343 |
| 67 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.65022343 |
| 68 | Lipid accumulation in hepatocytes (HP:0006561) | 2.64858354 |
| 69 | Muscle fiber splitting (HP:0003555) | 2.64494738 |
| 70 | EMG: neuropathic changes (HP:0003445) | 2.61865166 |
| 71 | Primary atrial arrhythmia (HP:0001692) | 2.60528141 |
| 72 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.58631896 |
| 73 | Vomiting (HP:0002013) | 2.58462678 |
| 74 | Dilated cardiomyopathy (HP:0001644) | 2.55327408 |
| 75 | Supraventricular tachycardia (HP:0004755) | 2.55000376 |
| 76 | * Increased serum lactate (HP:0002151) | 2.48603009 |
| 77 | Ulnar deviation of the wrist (HP:0003049) | 2.48238951 |
| 78 | Supraventricular arrhythmia (HP:0005115) | 2.47849234 |
| 79 | Abnormality of urine glucose concentration (HP:0011016) | 2.47798652 |
| 80 | Glycosuria (HP:0003076) | 2.47798652 |
| 81 | Calcaneovalgus deformity (HP:0001848) | 2.47414682 |
| 82 | Abnormality of serum amino acid levels (HP:0003112) | 2.47173055 |
| 83 | Increased connective tissue (HP:0009025) | 2.44924327 |
| 84 | Methylmalonic aciduria (HP:0012120) | 2.43286823 |
| 85 | Hypobetalipoproteinemia (HP:0003563) | 2.40863759 |
| 86 | CNS demyelination (HP:0007305) | 2.39637367 |
| 87 | Microvesicular hepatic steatosis (HP:0001414) | 2.38286683 |
| 88 | Abnormality of the foot musculature (HP:0001436) | 2.37228981 |
| 89 | Heart block (HP:0012722) | 2.37153965 |
| 90 | Neoplasm of the adrenal gland (HP:0100631) | 2.35912403 |
| 91 | Distal lower limb amyotrophy (HP:0008944) | 2.35856166 |
| 92 | Hyporeflexia of lower limbs (HP:0002600) | 2.35163281 |
| 93 | Leukodystrophy (HP:0002415) | 2.34650452 |
| 94 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.34097382 |
| 95 | Intrahepatic cholestasis (HP:0001406) | 2.32434811 |
| 96 | Ventricular arrhythmia (HP:0004308) | 2.31472075 |
| 97 | EMG: myopathic abnormalities (HP:0003458) | 2.30141579 |
| 98 | Muscle stiffness (HP:0003552) | 2.29401167 |
| 99 | Xanthomatosis (HP:0000991) | 2.29171774 |
| 100 | Nausea (HP:0002018) | 2.26295121 |
| 101 | Esophageal neoplasm (HP:0100751) | 2.22649344 |
| 102 | Neoplasm of head and neck (HP:0012288) | 2.22649344 |
| 103 | Reticulocytosis (HP:0001923) | 2.20242619 |
| 104 | Hypolipoproteinemia (HP:0010981) | 2.20179859 |
| 105 | Abnormal atrioventricular conduction (HP:0005150) | 2.19503061 |
| 106 | Cholelithiasis (HP:0001081) | 2.19264462 |
| 107 | Prolonged QT interval (HP:0001657) | 2.19066840 |
| 108 | Progressive external ophthalmoplegia (HP:0000590) | 2.18491554 |
| 109 | Round ear (HP:0100830) | 2.16754205 |
| 110 | Increased purine levels (HP:0004368) | 2.16691420 |
| 111 | Hyperuricemia (HP:0002149) | 2.16691420 |
| 112 | Increased hepatocellular lipid droplets (HP:0006565) | 2.14953330 |
| 113 | Optic disc pallor (HP:0000543) | 2.14451808 |
| 114 | Hypoalphalipoproteinemia (HP:0003233) | 2.12743526 |
| 115 | Ventricular fibrillation (HP:0001663) | 2.12198491 |
| 116 | Bundle branch block (HP:0011710) | 2.11773558 |
| 117 | Multiple enchondromatosis (HP:0005701) | 2.11027692 |
| 118 | Generalized muscle weakness (HP:0003324) | 2.10896861 |
| 119 | Deformed tarsal bones (HP:0008119) | 2.10502576 |
| 120 | Foot dorsiflexor weakness (HP:0009027) | 2.10086005 |
| 121 | Subaortic stenosis (HP:0001682) | 2.09368153 |
| 122 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.09368153 |
| 123 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.08750031 |
| 124 | Abnormal gallbladder physiology (HP:0012438) | 2.07826172 |
| 125 | Cholecystitis (HP:0001082) | 2.07826172 |
| 126 | Frequent falls (HP:0002359) | 2.07081174 |
| 127 | Abnormal gallbladder morphology (HP:0012437) | 2.06618976 |
| 128 | Asymmetric septal hypertrophy (HP:0001670) | 2.06224067 |
| 129 | Myotonia (HP:0002486) | 2.05833775 |
| 130 | Areflexia of lower limbs (HP:0002522) | 2.05374746 |
| 131 | Difficulty running (HP:0009046) | 2.05227956 |
| 132 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.03249763 |
| 133 | Malignant hyperthermia (HP:0002047) | 1.92021913 |
| 134 | Abnormality of reticulocytes (HP:0004312) | 1.87858629 |
| 135 | Increased variability in muscle fiber diameter (HP:0003557) | 1.85464730 |
| 136 | Cortical dysplasia (HP:0002539) | 1.81582364 |
| 137 | Atrioventricular block (HP:0001678) | 1.78214163 |
| 138 | Absent phalangeal crease (HP:0006109) | 1.77851212 |
| 139 | Shoulder girdle muscle weakness (HP:0003547) | 1.77215834 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PDK4 | 5.04685811 |
| 2 | PDK3 | 5.04685811 |
| 3 | BCKDK | 4.95118101 |
| 4 | OBSCN | 4.03400704 |
| 5 | NEK1 | 3.36484664 |
| 6 | MYLK | 3.11185527 |
| 7 | PDK2 | 3.09881644 |
| 8 | EEF2K | 3.01589368 |
| 9 | LMTK2 | 2.85592844 |
| 10 | TTN | 2.85322299 |
| 11 | PHKG1 | 2.76953909 |
| 12 | PHKG2 | 2.76953909 |
| 13 | WNK4 | 2.51717207 |
| 14 | SCYL2 | 2.49152486 |
| 15 | PKN2 | 2.47862736 |
| 16 | SRPK1 | 2.31707628 |
| 17 | TRIB3 | 2.09399649 |
| 18 | NME1 | 2.02259717 |
| 19 | PINK1 | 1.83769312 |
| 20 | PBK | 1.78004705 |
| 21 | MAP2K4 | 1.77568150 |
| 22 | EIF2AK3 | 1.73949091 |
| 23 | TTK | 1.71568643 |
| 24 | OXSR1 | 1.55023992 |
| 25 | STK24 | 1.43838428 |
| 26 | RPS6KB2 | 1.42598600 |
| 27 | STK39 | 1.40804685 |
| 28 | WNK3 | 1.39142215 |
| 29 | TIE1 | 1.34825690 |
| 30 | MAP3K4 | 1.34544873 |
| 31 | PIK3CA | 1.28574989 |
| 32 | MAP3K12 | 1.28194520 |
| 33 | BUB1 | 1.26140721 |
| 34 | STK38L | 1.14856215 |
| 35 | GRK7 | 1.04675101 |
| 36 | STK16 | 1.01237424 |
| 37 | PAK3 | 1.01075226 |
| 38 | RIPK1 | 1.00304127 |
| 39 | MARK1 | 0.98175625 |
| 40 | INSRR | 0.98150925 |
| 41 | ILK | 0.97746017 |
| 42 | MAP3K6 | 0.97257227 |
| 43 | MAP2K7 | 0.96370353 |
| 44 | CAMK2D | 0.95070228 |
| 45 | EIF2AK1 | 0.94616657 |
| 46 | PLK4 | 0.92610245 |
| 47 | MAPK12 | 0.90329388 |
| 48 | RAF1 | 0.88053651 |
| 49 | LIMK1 | 0.80017313 |
| 50 | MAP3K7 | 0.79429788 |
| 51 | LATS2 | 0.76677537 |
| 52 | ARAF | 0.76413939 |
| 53 | ERBB3 | 0.76379742 |
| 54 | FLT3 | 0.73948300 |
| 55 | VRK2 | 0.73384883 |
| 56 | CAMK2G | 0.72424595 |
| 57 | PRKAA1 | 0.72079021 |
| 58 | CAMK2A | 0.71698764 |
| 59 | CASK | 0.71226994 |
| 60 | NEK9 | 0.70584433 |
| 61 | ICK | 0.69023202 |
| 62 | MINK1 | 0.67549428 |
| 63 | NME2 | 0.67213653 |
| 64 | PRKAA2 | 0.67171150 |
| 65 | EPHA4 | 0.64924649 |
| 66 | DAPK3 | 0.64340060 |
| 67 | RPS6KB1 | 0.63156222 |
| 68 | DAPK2 | 0.62517187 |
| 69 | PRPF4B | 0.61977057 |
| 70 | ALK | 0.61177559 |
| 71 | MST1R | 0.60860328 |
| 72 | DMPK | 0.60036818 |
| 73 | MAPKAPK5 | 0.59971912 |
| 74 | PIK3CG | 0.59104987 |
| 75 | KSR2 | 0.58292209 |
| 76 | TSSK6 | 0.58096138 |
| 77 | PDPK1 | 0.57838692 |
| 78 | MUSK | 0.55914608 |
| 79 | MAP3K5 | 0.55716814 |
| 80 | CDK19 | 0.53873563 |
| 81 | EPHA3 | 0.53194447 |
| 82 | SGK494 | 0.51979689 |
| 83 | SGK223 | 0.51979689 |
| 84 | PRKACG | 0.51499454 |
| 85 | MAPKAPK3 | 0.51003753 |
| 86 | PRKD1 | 0.50859255 |
| 87 | CDK11A | 0.50560020 |
| 88 | MAP2K1 | 0.50493828 |
| 89 | CSNK1E | 0.50224932 |
| 90 | PRKACA | 0.49831806 |
| 91 | CSNK2A2 | 0.49472010 |
| 92 | TESK2 | 0.48800909 |
| 93 | PTK2B | 0.48601728 |
| 94 | PDK1 | 0.47940524 |
| 95 | NTRK3 | 0.47594151 |
| 96 | EIF2AK2 | 0.46675523 |
| 97 | CDK15 | 0.46620545 |
| 98 | MAP3K13 | 0.46410483 |
| 99 | FGFR4 | 0.45732345 |
| 100 | RPS6KA4 | 0.44295219 |
| 101 | CDK18 | 0.44036483 |
| 102 | AURKB | 0.43822768 |
| 103 | MAP2K6 | 0.43403170 |
| 104 | CAMK2B | 0.42814074 |
| 105 | FGFR3 | 0.42657839 |
| 106 | PLK2 | 0.42460507 |
| 107 | FER | 0.41305031 |
| 108 | PRKCG | 0.41265034 |
| 109 | ROCK1 | 0.41179298 |
| 110 | CDK14 | 0.39866320 |
| 111 | MAP3K2 | 0.39712933 |
| 112 | PRKACB | 0.39504888 |
| 113 | MAP2K3 | 0.39359736 |
| 114 | KDR | 0.39234119 |
| 115 | NEK2 | 0.39203349 |
| 116 | ERBB4 | 0.39083045 |
| 117 | MAPK11 | 0.38998561 |
| 118 | CDK6 | 0.38757314 |
| 119 | DAPK1 | 0.36663615 |
| 120 | CCNB1 | 0.36128851 |
| 121 | AKT2 | 0.35419428 |
| 122 | SMG1 | 0.35367895 |
| 123 | MAPK4 | 0.35271442 |
| 124 | CAMK4 | 0.34304693 |
| 125 | WNK1 | 0.34010589 |
| 126 | PRKCE | 0.33525377 |
| 127 | CHEK1 | 0.33317599 |
| 128 | CSNK2A1 | 0.32564006 |
| 129 | SIK1 | 0.32252662 |
| 130 | ABL2 | 0.30961965 |
| 131 | PLK1 | 0.30146109 |
| 132 | MAP3K11 | 0.30079140 |
| 133 | BCR | 0.29794378 |
| 134 | STK38 | 0.29083330 |
| 135 | ROCK2 | 0.28382188 |
| 136 | CAMK1 | 0.28195886 |
| 137 | CDC7 | 0.27756480 |
| 138 | KSR1 | 0.27474667 |
| 139 | SGK2 | 0.26408552 |
| 140 | TRPM7 | 0.26396472 |
| 141 | DYRK1B | 0.26278951 |
| 142 | PRKDC | 0.26134151 |
| 143 | RPS6KA3 | 0.25400870 |
| 144 | ADRBK1 | 0.22734400 |
| 145 | RET | 0.21846906 |
| 146 | PRKD3 | 0.21785232 |
| 147 | SGK3 | 0.20070564 |
| 148 | GRK5 | 0.19792963 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.27613981 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.89023786 |
| 3 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.60216956 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.15574355 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.03293447 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.02622526 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.97117464 |
| 8 | * Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.95842298 |
| 9 | Parkinsons disease_Homo sapiens_hsa05012 | 2.71996491 |
| 10 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.70407764 |
| 11 | Carbon metabolism_Homo sapiens_hsa01200 | 2.62148406 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.44630604 |
| 13 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.44183886 |
| 14 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.27926515 |
| 15 | * Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.96682966 |
| 16 | Alzheimers disease_Homo sapiens_hsa05010 | 1.96016460 |
| 17 | Ribosome_Homo sapiens_hsa03010 | 1.87602652 |
| 18 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.84984875 |
| 19 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.84222099 |
| 20 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.72942499 |
| 21 | * Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.72499224 |
| 22 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.70722751 |
| 23 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.67745632 |
| 24 | Huntingtons disease_Homo sapiens_hsa05016 | 1.67238222 |
| 25 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.65979623 |
| 26 | Peroxisome_Homo sapiens_hsa04146 | 1.59445068 |
| 27 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.56930754 |
| 28 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.55593425 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.47226038 |
| 30 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.45429809 |
| 31 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.44753420 |
| 32 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.40717926 |
| 33 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.36708663 |
| 34 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.29396147 |
| 35 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.20322898 |
| 36 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.17065155 |
| 37 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.13950142 |
| 38 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.08248832 |
| 39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.08046938 |
| 40 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.99620162 |
| 41 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.87920695 |
| 42 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.86975712 |
| 43 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.83916420 |
| 44 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.83610784 |
| 45 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.82597854 |
| 46 | DNA replication_Homo sapiens_hsa03030 | 0.82120242 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.82112512 |
| 48 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.81772505 |
| 49 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.81639664 |
| 50 | Bile secretion_Homo sapiens_hsa04976 | 0.79546346 |
| 51 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.78402330 |
| 52 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.78088708 |
| 53 | Spliceosome_Homo sapiens_hsa03040 | 0.72799407 |
| 54 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.70036405 |
| 55 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.69579548 |
| 56 | RNA transport_Homo sapiens_hsa03013 | 0.68241384 |
| 57 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.68022226 |
| 58 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.67403170 |
| 59 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.66555655 |
| 60 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.66140980 |
| 61 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.65807848 |
| 62 | Proteasome_Homo sapiens_hsa03050 | 0.63385292 |
| 63 | Mismatch repair_Homo sapiens_hsa03430 | 0.62254008 |
| 64 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.61906054 |
| 65 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.60899519 |
| 66 | Histidine metabolism_Homo sapiens_hsa00340 | 0.60023153 |
| 67 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.59992169 |
| 68 | Galactose metabolism_Homo sapiens_hsa00052 | 0.58812563 |
| 69 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.57530283 |
| 70 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.57004099 |
| 71 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.55837083 |
| 72 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.55354798 |
| 73 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.53241697 |
| 74 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.53132178 |
| 75 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.50799666 |
| 76 | Base excision repair_Homo sapiens_hsa03410 | 0.50364583 |
| 77 | Circadian rhythm_Homo sapiens_hsa04710 | 0.50178874 |
| 78 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.47829048 |
| 79 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.46728101 |
| 80 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.46413726 |
| 81 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.43540915 |
| 82 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.42275405 |
| 83 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.41556474 |
| 84 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41199292 |
| 85 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.41149357 |
| 86 | Purine metabolism_Homo sapiens_hsa00230 | 0.41114903 |
| 87 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.38904789 |
| 88 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.38886709 |
| 89 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.38528262 |
| 90 | Insulin resistance_Homo sapiens_hsa04931 | 0.38367498 |
| 91 | Other glycan degradation_Homo sapiens_hsa00511 | 0.37739680 |
| 92 | Retinol metabolism_Homo sapiens_hsa00830 | 0.37374550 |
| 93 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.33248757 |
| 94 | Mineral absorption_Homo sapiens_hsa04978 | 0.31279957 |
| 95 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.30833730 |
| 96 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.30632356 |
| 97 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.29529364 |
| 98 | Lysine degradation_Homo sapiens_hsa00310 | 0.29390655 |
| 99 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.28512798 |
| 100 | Sulfur relay system_Homo sapiens_hsa04122 | 0.28080222 |
| 101 | RNA degradation_Homo sapiens_hsa03018 | 0.23334513 |
| 102 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.20567345 |
| 103 | ABC transporters_Homo sapiens_hsa02010 | 0.19908480 |
| 104 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.19484082 |
| 105 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.18846864 |
| 106 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.17678051 |
| 107 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.16782985 |
| 108 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.16589044 |
| 109 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.15981571 |
| 110 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.15795238 |
| 111 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.15708330 |
| 112 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.15410781 |
| 113 | Renin secretion_Homo sapiens_hsa04924 | 0.14704467 |
| 114 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.14463651 |
| 115 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.12961068 |
| 116 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.12955429 |
| 117 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.09866028 |
| 118 | GABAergic synapse_Homo sapiens_hsa04727 | 0.09277723 |
| 119 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.06869198 |
| 120 | Insulin secretion_Homo sapiens_hsa04911 | 0.06862810 |
| 121 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.02882243 |
| 122 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.02398652 |
| 123 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.01868847 |

